4//SEC Filing
HORAK IVAN D 4
Accession 0000930413-11-002495
CIK 0000727510other
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 6:12 PM ET
Size
7.3 KB
Accession
0000930413-11-002495
Insider Transaction Report
Form 4
HORAK IVAN D
EVP, R&D, Chief Scientific Off
Transactions
- Other
Common Stock
2011-03-30+2,500→ 122,262 total - Tax Payment
Common Stock
2011-03-30$10.76/sh−886$9,533→ 121,376 total
Footnotes (3)
- [F1]Shares acquired upon vesting of a portion of restricted stock units granted to the Reporting Person on September 22, 2010 and reported on a Form 4 filed on September 24, 2010. Vesting of 1/6 of the shares underlying the award was accelerated by the Board.
- [F2]The Reporting Person previously reported all restricted stock units granted to the Reporting Person on September 22, 2010 in Table I of the Form 4 filed on September 24, 2010. As such, no adjustment to the Reporting Person's beneficial ownership needs to be made to reflect this vesting event.
- [F3]Shares were withheld from the Reporting Person, in an exempt transaction under Rule 16b-3, solely to satisfy tax obligations arising from the vesting of the restricted stock units described in this Form 4.
Documents
Issuer
ENZON PHARMACEUTICALS INC
CIK 0000727510
Entity typeother
Related Parties
1- filerCIK 0001247903
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 6:12 PM ET
- Size
- 7.3 KB